TD Asset Management Inc grew its stake in shares of Masimo Corporation (NASDAQ:MASI – Free Report) by 6.2% in the 4th quarter, HoldingsChannel reports. The fund owned 114,514 shares of the medical equipment provider’s stock after purchasing an additional 6,656 shares during the quarter. TD Asset Management Inc’s holdings in Masimo were worth $14,894,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Masimo by 3.7% during the third quarter. Vanguard Group Inc. now owns 4,810,011 shares of the medical equipment provider’s stock worth $709,717,000 after acquiring an additional 171,876 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in Masimo by 1.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock worth $346,464,000 after acquiring an additional 43,915 shares during the last quarter. State Street Corp lifted its position in Masimo by 0.7% during the second quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock worth $250,041,000 after acquiring an additional 10,403 shares during the last quarter. Westfield Capital Management Co. LP lifted its position in Masimo by 20.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,419,250 shares of the medical equipment provider’s stock worth $209,410,000 after acquiring an additional 238,047 shares during the last quarter. Finally, Alyeska Investment Group L.P. lifted its position in Masimo by 21.7% during the third quarter. Alyeska Investment Group L.P. now owns 1,381,085 shares of the medical equipment provider’s stock worth $203,779,000 after acquiring an additional 246,595 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several brokerages have issued reports on MASI. Wells Fargo & Company upgraded shares of Masimo to a “hold” rating in a research report on Wednesday, March 18th. BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Wolfe Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Weiss Ratings raised shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Finally, Raymond James Financial cut shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Nine investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, Masimo presently has a consensus rating of “Hold” and a consensus target price of $180.40.
Masimo Stock Performance
Shares of NASDAQ:MASI opened at $179.94 on Tuesday. The company’s 50 day simple moving average is $178.51 and its 200 day simple moving average is $159.66. The stock has a market capitalization of $9.42 billion, a price-to-earnings ratio of -17.07, a price-to-earnings-growth ratio of 1.81 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45. Masimo Corporation has a 1 year low of $125.94 and a 1 year high of $179.97.
Masimo Profile
Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.
In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.
Read More
- Five stocks we like better than Masimo
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI – Free Report).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.
